United Therapeutics CorporationUTHRNASDAQ
LOADING
|||
Gross Profit Over Time
Trending higher, above historical average, modest growth trend.
Left:
||||
Revenue minus cost of goods sold
Latest
$2.57B
↑ 54% above average
Average (9y)
$1.67B
Historical baseline
Range
High:$2.57B
Low:$1.33B
CAGR
+7.0%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $2.57B | +24.0% |
| 2023 | $2.07B | +15.7% |
| 2022 | $1.79B | +14.5% |
| 2021 | $1.56B | +13.7% |
| 2020 | $1.38B | +3.3% |
| 2019 | $1.33B | -6.9% |
| 2018 | $1.43B | -11.8% |
| 2017 | $1.62B | +6.1% |
| 2016 | $1.53B | +9.3% |
| 2015 | $1.40B | - |